WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2'2801 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 1'9101 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 104  102  101  99  98  83  71  55 
Births
Surviving infants
Pop. less than 5 years 11  11  11  11  11  12  11 
Pop. less than 15 years 33  33  33  33  33  33  29  22 
Female 15-49 years 28  28  27  27  26  21  17  13 

Number of reported case

(Click for retrospective incidence data for Kiribati)
Diphtheria
Japanese encephalitis
Measles 30  170 
Mumps
Pertussis 830  161 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kiribati)
Vaccine year result method % card seen                                                
BCG 2008  89  DHS   22  72  86  95  86  87  80  93  66 
DTP1 2008  82  DHS   22  83  95  94  99*  90  95 
DTP3 2008  61  DHS   22  75  95  94  99  91  90  97  43 
DTP4         
IPV1         
HepB_BD          66  84  82  66  63  80 
HepB3 2008  61  DHS   22  75  95  94  95  91  90  73 
Hib3 2008  61  DHS   22  75  95  94  95  91 
JapEnc         
MCV1          91  91  90  89  80  75 
MCV2          84  61  21 
PCV1          70  62 
PCV3          57  40 
Pol3 2008  48  DHS   22  79  91  92  95  95  90  97  10 
Rota1         
Rota_last         
Rubella1          91  91  90 
TT2plus 2008  44  DHS   22  83  99*  83  50  54 
PAB         
VAD1          76  99*  58 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kiribati)
BCG 72  86  95  86  87  80  93  66 
DTP1 83  95  94  99  97  95  98  68 
DTP3 75  95  94  99  91  90  97  43 
HepB3 75  95  94  95  91  90  73 
HepB_BD 66  84  82  66  63  80 
Hib3 75  95  94  95  91 
MCV1 91  91  91  90  89  80  75 
MCV2 84  84  61  21 
PCV3 57  40 
Pol3 79  91  92  95  95  90  97  10 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
93 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 17
From 50 to 79% 17
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
16
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9-13 years; No
HepB birth; Yes
IPV 14 weeks; Yes From June 2015
MR 12 months; 6 years; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From June 2015
TT 13 years; Yes
VitaminA 6-12 months; 13 months to 6 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2013-2015  2013-2017  2008-2012  2008-2012  2008-2012   
Nº of districts with microplans that include activities to raise immunization coverage number    

System performance

Total Nº districts in country number 24 
Nº districts with DTP3 coverage >=80% number 11 
% of districts with DTP3 coverage >=80% From 0 to 100% 67  100  100  83  83  46 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 50  50  17  17  33   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   100    111    100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.